Kallikrein 7 Antikörper (AA 1-237)
Kurzübersicht für Kallikrein 7 Antikörper (AA 1-237) (ABIN1885824)
Target
Alle Kallikrein 7 (KLK7) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-237
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 237 of Human KLK7
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- Kallikrein 7 (KLK7)
-
Andere Bezeichnung
- KLK7
-
Hintergrund
-
Kallikreins are a subgroup of serine proteases having diverse physiological functions.Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers.This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19.Its encoded enzyme is thought to be involved in the proteolysis of intercellular cohesive structures preceding desquamation, which is the shedding of the outermost layer of the epidermis.Alternative splicing of this gene results in two transcript variants encoding the same protein.[provided by RefSeq]
Synonyms: PRSS6 -
Molekulargewicht
- 28 kDa
-
Gen-ID
- 5650
-
NCBI Accession
- NP_005037, NM_005046
-
Pathways
- Komplementsystem
Target
-